Prevalence of and disparities in adolescents' susceptibility to novel oral nicotine products marketed as "tobacco-free".
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Vogel (2023)
Differences in Young adults' Perceptions of and Willingness to Use Nicotine Pouches by Tobacco Use Status
Population Clinical
Perception Of Risk
Comparison With Other Tobacco Products
Vogel (2022)
Comparison of self-rated oral symptoms and periodontal status among cigarette smokers and individuals using electronic nicotine delivery systems.
Individual Clinical
Safety
Adverse Effects
Vohra (2020)
Randomized within‐subject trial to evaluate smokers’ initial perceptions, subjective effects and nicotine delivery across six vaporized nicotine products.
Population Clinical
Cessation
Tobacco
Voos (2019)
What is the nicotine delivery profile of electronic cigarettes?
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Voos (2019)
Effect of e-cigarette flavors on nicotine delivery and puffing topography: results from a randomized clinical trial of daily smokers.
Individual Clinical
User Topography
Voos (2020)
a simple predictive model for estimating relative e-cigarette toxic carbonyl levels.
Nonclinical
Chemical
Analysis
Vreeke (2020)
age differences in electronic nicotine delivery systems (ENDS) usage motivations and behaviors, perceived health benefit, and intention to quit.
Population Clinical
Consumer Use
Reasons For Use
Vu (2019)
Predicting the long-term effects of electronic cigarette use on population health: a systematic review of modelling studies.
Population Clinical
Population Health Impact
Vu (2023)
Perceptions about levels of harmful chemicals in e-cigarettes relative to cigarettes, and associations with relative e-cigarette harm perceptions, e-cigarette use and interest.
Population Clinical
Perceptions Of Risk
Comparison With Tobacco Or Other Nicotine Products
Wackowski (2023)